Actively Recruiting
Mandibular Splint vs Botox Injection in Lateral Pterygoid on Cervical Muscle Activity in Patients With Temporomandibular Disorders
Led by Cairo University · Updated on 2024-08-16
33
Participants Needed
1
Research Sites
24 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study aims to compere mandibular splint versus botox injection in lateral pterygoid on cervical muscle activity in patients with temporomandibular disorders
CONDITIONS
Official Title
Mandibular Splint vs Botox Injection in Lateral Pterygoid on Cervical Muscle Activity in Patients With Temporomandibular Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age from 18-40 years old.
- Both sexes.
- Duration of the disease is more than 3 months.
- Anterior mandibular disc displacement with reduction.
- Unilateral anterior mandibular displacement with reduction grade 2 and 3 (Wilkes).
- Patients with cervical muscle spasm and trigger points (upper trapezius and sternocleidomastoid).
- Patients with sufficient cognitive abilities to understand and follow instructions.
You will not qualify if you...
- Neurological or musculoskeletal diseases affecting cervical spine other than mandibular disc displacement (e.g., cervical spondylosis, spondylolisthesis, cervical disc injuries).
- Bilateral anterior mandibular disc displacement.
- Severe musculoskeletal disorders such as arthritis, cervical spine surgery, contractures, or leg length discrepancy.
- Women who are pregnant or breastfeeding.
- Known hypersensitivity to any drug components, especially human albumin.
- Infection or inflammation at planned injection sites.
- Musculoskeletal conduction disorders and primary muscular disorders (e.g., muscular dystrophy, neuromyopathy).
- Current treatment with certain antibiotics or drugs (aminoglycosides, ciclosporin, D-penicillamine, etc.).
- History of cervical spine surgery or trauma.
- Signs of cervical radiculopathy, myelopathy, or vascular syndromes.
- Signs of serious pathology such as malignancy, inflammatory disorders, or infection.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cairo University
Cairo, Egypt, 11796
Actively Recruiting
Research Team
K
Kerolos G Abd-El Malak, MBBCH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here